IL6 and esophageal cancer: TRIM29 has been reported to inhibit cytokine production, such as IL6, and TRIM29 knockdown markedly enhanced the production of these cytokines [20, 21, 42, 43], which could activate STAT3 in multiple tumors, including esophageal cancer [44–47].